| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/06/2008 | CN101119706A Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 02/06/2008 | CN101116742A Non-aqueous polar aprotic peptide formulations comprising lhrh-related compounds |
| 02/06/2008 | CN101116673A Middle gut positioning sausage dissolvable pharmaceutical formulations for relieving diarrhea and processes for their preparation |
| 02/06/2008 | CN101116666A Compositions of estrogen-cyclodextrin complexes |
| 02/06/2008 | CN101116665A Malaria-resisting arteannuin naphthoquine compound composition |
| 02/06/2008 | CN101116663A Percutaneously absorbable preparation for treating male sexual disfunction and method for preparing the same |
| 02/06/2008 | CN101116657A Externally- used contraception emulsion and method for preparing the same |
| 02/06/2008 | CN101116656A Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
| 02/06/2008 | CN101116512A Enteral feeding solutions contain an alkyl paraben to inhibit growth of micro-organisms in the enteral tube |
| 02/06/2008 | CN100366297C Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 02/06/2008 | CN100366296C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 02/06/2008 | CN100366295C Composition for intestinal delivery |
| 02/06/2008 | CN100366294C Oral cavity quick dissolving preparation and production method thereof |
| 02/06/2008 | CN100366289C Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 02/06/2008 | CN100366256C Ciclesonide-containing sterile aqueous suspension |
| 02/06/2008 | CN100366253C 1,2,4-benzotriazine oxides formulations |
| 02/06/2008 | CN100366251C Organic compounds |
| 02/06/2008 | CN100366250C Freeze dried vinpocetine powder injection and its preparation process |
| 02/06/2008 | CN100366244C Local used composition containing antifungal agent |
| 02/06/2008 | CN100366240C Ultraviolet-shielding type patch |
| 02/06/2008 | CN100366238C Freeze dried polyene lecithin powder for injection and its prepn |
| 02/05/2008 | US7326692 Induction of immunity using inhibitors of granzymes |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326427 Tablet composition containing Kampo medicinal extract and its manufacturing process |
| 02/05/2008 | US7326426 Compositions and medical devices utilizing bioabsorbable liquid polymers |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326422 Dissolvable oxides for biological applications |
| 02/05/2008 | US7326404 Konjac-mannan and ginseng compositions and methods and uses thereof |
| 02/05/2008 | CA2436269C Artificial tear composition containing a combination of three demulcents |
| 02/05/2008 | CA2390746C Quinolinone derivative pharmaceutical composition and production method therefor |
| 02/05/2008 | CA2315685C Molecular dispersion composition with enhanced bioavailability |
| 02/05/2008 | CA2307607C Powdery nasal compositions |
| 02/05/2008 | CA2302276C Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 02/05/2008 | CA2293720C Improved method for preparing low-concentration polyaluminosilicate microgels |
| 02/05/2008 | CA2218161C Peptide compositions with growth factor-like activity |
| 02/05/2008 | CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof |
| 02/05/2008 | CA2156255C Soluble thrombomodulin-containing composition |
| 02/01/2008 | WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 02/01/2008 | CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes |
| 01/31/2008 | WO2008014060A2 Microparticle |
| 01/31/2008 | WO2008014036A1 Aqueous gel formulation and method for inducing topical anesthesia |
| 01/31/2008 | WO2008013807A2 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 01/31/2008 | WO2008013735A2 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 01/31/2008 | WO2008013302A1 Jelly for endoscopic swallowing evaluation |
| 01/31/2008 | WO2008013197A1 Spherical crude granule and method for production thereof |
| 01/31/2008 | WO2008013084A1 Sugar-coated preparation and process for producing the same |
| 01/31/2008 | WO2008012548A1 Linseed extract medicament for application to the eye |
| 01/31/2008 | WO2008012528A1 N-terminal polysialylation |
| 01/31/2008 | WO2008012525A1 Derivatisation of granulocyte colony-stimulating factor |
| 01/31/2008 | WO2008012365A2 Drug delivery system based on regioselectively amidated hyaluronic acid |
| 01/31/2008 | WO2008012102A2 Radiodense conjugate |
| 01/31/2008 | WO2008012086A2 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 01/31/2008 | WO2008011915A1 Masking the taste of compositions containing salt |
| 01/31/2008 | WO2008011812A1 Biomimetic cell membrane of phospholipid polymer, preparation method and use thereof |
| 01/31/2008 | WO2007143382A3 Oral liquid loratadine formulations and methods |
| 01/31/2008 | WO2007139804A3 Compositions and methods for treating conditions of the nail unit |
| 01/31/2008 | WO2007133944A3 Topical administration of acyclovir |
| 01/31/2008 | WO2007103425A3 Kits and methods for preparing pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) |
| 01/31/2008 | WO2007087350A3 Methods for regulating gelation of polysaccharide solutions and uses thereof |
| 01/31/2008 | WO2007082897A3 Polysaccharide-cyclodextrin conjugates |
| 01/31/2008 | WO2007075720A3 Topical mecamylamine formulations for ocular administration and uses thereof |
| 01/31/2008 | WO2007049017A3 Agents that bind a target in pulmonary tissue for treating respiratory diseases |
| 01/31/2008 | US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027144 A dicarboxylic acid compound obtainable by oxidative degradation of pradimicin antibiotics; improved water-solubility |
| 01/31/2008 | US20080027130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 01/31/2008 | US20080027033 Method and Composition for Treatment of Cutaneous Lesions |
| 01/31/2008 | US20080027011 Homogeneous paste and gel formulations |
| 01/31/2008 | US20080026984 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 01/31/2008 | US20080026444 Process For Producing Protein-Polymer Complex |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026070 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 01/31/2008 | US20080026066 Liquids Containing Suspended Glass Particles |
| 01/31/2008 | US20080026065 Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State |
| 01/31/2008 | US20080026046 Stable Aqueous G-Csf Conatining Compositions |
| 01/31/2008 | US20080026044 Combination Chemotherapy Comprising Capecitabine and a Liposomal Platinum Complex |
| 01/31/2008 | US20080026043 Transdermal Therapeutic System Comprising an Adhesive Layer Method for Siliconizing the Back Layer or the System and Use of Said Back Layer |
| 01/31/2008 | US20080026014 Nasal Stick for the Application of Medicaments and Skin Care Substances |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025996 Methods and Compositions Comprising Polycationic Compounds |
| 01/31/2008 | US20080025994 Methods and compositions for the treatment of pancreatitis |
| 01/31/2008 | US20080025950 Modified Macromolescules and Associated Methods of Synthesis and Use |
| 01/31/2008 | US20080025913 Novel Anti-Dc-Sign Antibodies |
| 01/31/2008 | US20080023345 Packages for ophthalmic lenses containing pharmaceutical agents |
| 01/31/2008 | CA2659225A1 Immunogenic compounds and protein mimics |
| 01/31/2008 | CA2658654A1 Exendin fusion proteins |
| 01/31/2008 | CA2658646A1 Ophthalmic solutions |
| 01/31/2008 | CA2658587A1 Drug delivery system based on regioselectively amidated hyaluronic acid |
| 01/31/2008 | CA2658436A1 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 01/31/2008 | CA2658314A1 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 01/30/2008 | EP1882480A2 High glycerin containing anti-microbial cleansers |
| 01/30/2008 | EP1881850A1 Glp-1 pegylated compounds |
| 01/30/2008 | EP1881849A2 Vascular targeting of ocular neovascularization |
| 01/30/2008 | EP1881848A2 Prevention of hiv-infection with tmc278 |
| 01/30/2008 | EP1881847A2 Injection solution for rna |
| 01/30/2008 | EP1881835A1 Triazine compounds and compositions thereof for the treatment of cancers |
| 01/30/2008 | EP1881818A1 Composition for treatment of a detached retina and method of production thereof |
| 01/30/2008 | EP1881813A2 Cosmetic composition for diminishing the appearance of lines and pores |